Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats

• Main Authors: Charoenphandhu N., Suntornsaratoon P., Krishnamra N., Sa-nguanmoo P., Tanajak P., Wang X., Liang G., Li X., Jiang C., Chattipakorn N., Chattipakorn S.
• 格式: 雜誌
• 出版: 2017
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84962293972&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/40692
• 機構: Chiang Mai University

© 2016, The Japanese Society for Bone and Mineral Research and Springer Japan. Fibroblast growth factor (FGF)-21 is a potent endocrine factor that improves insulin resistance and obesity-associated metabolic disorders. However, concomitant activation of peroxisome proliferator-activated receptor-γ b...